In this review, we summarize the recent developments in this field focussing on non-oral dopamine replacement therapy strategies in development or to be licensed for management of PD
Exploring the Structure Image JSmol Compare how GLP-1, exendin-4 and GIP bind to receptors GLP-1 (PDB 6B3J), exendin-4 (PDB 7LLL) and GIP (PDB 7RA3) bind to receptors in a similar way, with one end of the peptide binding deep within a pocket in the transmembrane domain of the receptor, and the other end of the peptide binding to the extracellular domain
The Strategy: Opt for lower-sugar options like dry wine, light beer, or spirits mixed with soda water and fresh lime." 4
Arch Ophthamol 2011;129:767-772
Only the second category has a defensible claim
Semaglutide uses a gradual titration approach, starting at a low dose and increasing over time